Oppenheimer Holdings, Inc. Analysts Give ReWalk Robotics Ltd (NASDAQ:RWLK) a $4.00 Price Target
Oppenheimer Holdings, Inc. set a $4.00 target price on ReWalk Robotics Ltd (NASDAQ:RWLK) in a report issued on Friday morning. The firm currently has a buy rating on the medical device company’s stock.
A number of other research analysts also recently issued reports on RWLK. Canaccord Genuity reissued a buy rating on shares of ReWalk Robotics in a research note on Monday, June 12th. Zacks Investment Research raised ReWalk Robotics from a hold rating to a buy rating and set a $1.50 price objective on the stock in a research note on Thursday, May 11th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. ReWalk Robotics currently has a consensus rating of Hold and a consensus price target of $4.00.
ReWalk Robotics (NASDAQ RWLK) traded down 9.1871% during trading on Friday, reaching $1.4076. The company’s stock had a trading volume of 620,153 shares. The company’s 50 day moving average price is $1.58 and its 200-day moving average price is $1.77. ReWalk Robotics has a 1-year low of $1.10 and a 1-year high of $7.85. The stock’s market cap is $23.47 million.
ReWalk Robotics (NASDAQ:RWLK) last announced its earnings results on Thursday, August 3rd. The medical device company reported ($0.29) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.35) by $0.06. The firm had revenue of $2.01 million for the quarter, compared to the consensus estimate of $1.71 million. ReWalk Robotics had a negative return on equity of 528.26% and a negative net margin of 389.13%. The business’s quarterly revenue was up 145.7% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.64) EPS. Equities analysts forecast that ReWalk Robotics will post ($1.30) earnings per share for the current fiscal year.
TRADEMARK VIOLATION NOTICE: This piece of content was published by Daily Political and is the property of of Daily Political. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States and international copyright law. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/08/07/oppenheimer-holdings-inc-analysts-give-rewalk-robotics-ltd-nasdaqrwlk-a-4-00-price-target.html.
In other ReWalk Robotics news, major shareholder Scp Vitalife Partners Ii Lp sold 65,218 shares of the business’s stock in a transaction that occurred on Tuesday, June 27th. The stock was sold at an average price of $3.05, for a total transaction of $198,914.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Wayne Weisman sold 87,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 27th. The stock was sold at an average price of $3.05, for a total value of $265,350.00. The disclosure for this sale can be found here. Insiders sold a total of 199,883 shares of company stock valued at $604,772 over the last ninety days. 13.70% of the stock is currently owned by corporate insiders.
A hedge fund recently raised its stake in ReWalk Robotics stock. Renaissance Technologies LLC increased its position in ReWalk Robotics Ltd (NASDAQ:RWLK) by 171.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 48,600 shares of the medical device company’s stock after buying an additional 30,700 shares during the period. Renaissance Technologies LLC owned about 0.30% of ReWalk Robotics worth $136,000 at the end of the most recent quarter. 4.69% of the stock is currently owned by institutional investors and hedge funds.
About ReWalk Robotics
ReWalk Robotics Ltd. is a medical device company. The Company is engaged in designing, developing and commercializing exoskeletons that allow individuals with mobility impairments or other medical conditions the ability to stand and walk once again. The Company offers ReWalk, which is an exoskeleton that uses its tilt-sensor technology and an on-board computer and motion sensors to drive motorized legs that power movement.
Receive News & Ratings for ReWalk Robotics Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ReWalk Robotics Ltd and related companies with MarketBeat.com's FREE daily email newsletter.